After semaglutide, the new star drug for weight loss, "Mounjaro", was officially launched in China. On the evening of December 23, the media found that the first GLP-1 dual-target drug Mounjaro had been launched for a limited time on Meituan. People close to Meituan revealed that it was sold out in 3 seconds on the first night, and the number of reservations increased by more than three times on a daily basis. Currently, supply is gradually catching up with demand, and it can be purchased all day from December 25. The merchant's customer service said that the demand for Mounjaro is currently hot, and they will continue to stock up to meet demand. It is reported that the supply may enter a stable state from January to February.